Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents
Introduction: Real-world studies of lower-risk myelodysplastic syndromes myelodysplastic syndromes: (my
